Kanagawa-ken, Japan

Keiko Shito


Average Co-Inventor Count = 12.6

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1997-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Keiko Shito: Innovator in Pharmaceutical Chemistry

Introduction

Keiko Shito is a prominent inventor based in Kanagawa-ken, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of tricyclic compounds. With a total of 3 patents, her work has advanced the understanding and application of pharmacologically active compounds.

Latest Patents

Among her latest patents are innovative compounds that serve as intermediates for pharmacologically active tricyclic benzazepine and benzothiazepine derivatives. These include tricyclic benzazepine compounds and triazole intermediates for tricyclic benzazepine and benzothiazepine. The compounds of formulae (II), (III), (IV), and (V) or their salts represent a significant advancement in the field, where R can denote hydrogen, alkyl, phenylalkyl, or a protective group of a triazole ring. Additionally, R¹-R⁵ can represent various functional groups, enhancing the versatility of these compounds.

Career Highlights

Keiko Shito has worked with notable companies such as Meiji Seika Kabushiki Kaisha and Meiji Seika Kaisha, Ltd. Her experience in these organizations has allowed her to collaborate on various innovative projects, furthering her expertise in pharmaceutical development.

Collaborations

Throughout her career, Keiko has collaborated with esteemed colleagues, including Yasuo Ohtsuka and Takashi Shishikura. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Keiko Shito's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as an influential inventor. Her work continues to impact the field, paving the way for future innovations in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…